Literature DB >> 9126499

The increasing incidence of lung adenocarcinoma: reality or artefact? A review of the epidemiology of lung adenocarcinoma.

A Charloux1, E Quoix, N Wolkove, D Small, G Pauli, H Kreisman.   

Abstract

Lung adenocarcinoma is the most common cell type in females (smokers or non-smokers) and in non-smoking males. Its incidence has been increasing in younger cohorts of males and females until very recent years. Changes in classification and in pathological techniques account for some of this increase. In females and non-smoker males, the increase could be partly due to a detection bias in former studies. Nevertheless, successive cohorts over time seem more likely to develop adenocarcinoma and less likely to develop squamous cell carcinoma. These differences between birth cohorts suggest that the increasing incidence of adenocarcinoma is not only due to changes in pathological diagnosis. Geographical differences are also observed: in Europe, the squamous cell type still predominates and an increase in incidence of adenocarcinoma has only been reported in the Netherlands. In Asia, in the 1960s and 1970s, the proportion of adenocarcinoma was higher than in North America or Europe and seems to be increasing. To what extent these differences are due to differences. In establishing diagnosis remains unknown. Despite these biases in temporal and geographical trends detailed in this review, there has probably been a true increase in incidence of adenocarcinoma. An explanation for this should be sought in studies on detailed smoking history and passive smoking exposure, occupational exposure, diet and cooking, pollution and other environmental factors.

Entities:  

Mesh:

Year:  1997        PMID: 9126499     DOI: 10.1093/ije/26.1.14

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  60 in total

1.  Serum lactate dehydrogenase levels at presentation in stage IV non-small cell lung cancer: predictive value of metastases and relation to survival outcomes.

Authors:  Dong Soo Lee; Kyung Ran Park; Seung Joon Kim; Mi Joo Chung; Yun Hee Lee; Ji Hyun Chang; Jin Hyoung Kang; Sook Hee Hong; Myung Sin Kim; Yeon Sil Kim
Journal:  Tumour Biol       Date:  2015-08-04

2.  The consequences of the unregulated cigarette.

Authors:  Nigel Gray
Journal:  Tob Control       Date:  2006-10       Impact factor: 7.552

Review 3.  The pivotal role of pathology in the management of lung cancer.

Authors:  Morgan R Davidson; Adi F Gazdar; Belinda E Clarke
Journal:  J Thorac Dis       Date:  2013-10       Impact factor: 2.895

4.  Identification and Characterization of Potential Biomarkers by Quantitative Tissue Proteomics of Primary Lung Adenocarcinoma.

Authors:  Chiung-Hung Hsu; Chia-Wei Hsu; Chuen Hsueh; Chih-Liang Wang; Yi-Cheng Wu; Chih-Ching Wu; Chin-Ching Liu; Jau-Song Yu; Yu-Sun Chang; Chia-Jung Yu
Journal:  Mol Cell Proteomics       Date:  2016-05-09       Impact factor: 5.911

5.  Prognostic factors for long term survival in patients with advanced non-small cell lung cancer.

Authors:  Despoina Moumtzi; Sofia Lampaki; Paul Zarogoulidis; Konstantinos Porpodis; Kalliopi Lagoudi; Wolfgang Hohenforst-Schmidt; Athanasia Pataka; Theodora Tsiouda; Athanasios Zissimopoulos; George Lazaridis; Vasilis Karavasilis; Helen Timotheadou; Nikolaos Barbetakis; Pavlos Pavlidis; Theodoros Kontakiotis; Konstantinos Zarogoulidis
Journal:  Ann Transl Med       Date:  2016-05

6.  The Burden of Cancer in Asian Americans: A Report of National Mortality Trends by Asian Ethnicity.

Authors:  Caroline A Thompson; Scarlett Lin Gomez; Katherine G Hastings; Kristopher Kapphahn; Peter Yu; Salma Shariff-Marco; Ami S Bhatt; Heather A Wakelee; Manali I Patel; Mark R Cullen; Latha P Palaniappan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-10       Impact factor: 4.254

Review 7.  Lung cancer in HIV infected patients: facts, questions and challenges.

Authors:  J Cadranel; D Garfield; A Lavolé; M Wislez; B Milleron; C Mayaud
Journal:  Thorax       Date:  2006-11       Impact factor: 9.139

8.  Calibration of disease simulation model using an engineering approach.

Authors:  Chung Yin Kong; Pamela M McMahon; G Scott Gazelle
Journal:  Value Health       Date:  2009-01-12       Impact factor: 5.725

9.  Pemetrexed and cisplatin combination with concurrent whole brain radiotherapy in patients with brain metastases of lung adenocarcinoma: a single-arm phase II clinical trial.

Authors:  Xiao-Xiao Dinglin; Yan Huang; Hui Liu; Yin-Duo Zeng; Xue Hou; Li-Kun Chen
Journal:  J Neurooncol       Date:  2013-02-19       Impact factor: 4.130

10.  Epidemiology of non-small cell lung cancer in Asian Americans: incidence patterns among six subgroups by nativity.

Authors:  Dan J Raz; Scarlett L Gomez; Ellen T Chang; Jae Y Kim; Theresa H M Keegan; Jane Pham; Jasleen Kukreja; Robert A Hiatt; David M Jablons
Journal:  J Thorac Oncol       Date:  2008-12       Impact factor: 15.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.